Credit Suisse Upgraded ResMed (RMD) to Neutral Following Q3 Results
Go back to Credit Suisse Upgraded ResMed (RMD) to Neutral Following Q3 Results| RESMED, Inc. (NYSE: RMD) | Delayed: 219.98 -0.39 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $220.37 | 52 Week High | $70.90 | |||
| Open | $221.00 | 52 Week Low | $50.77 | |||
| Day High | $223.47 | P/E | 98.65 | |||
| Day Low | $219.97 | EPS | $2.23 | |||
| Volume | 1,294,457 | |||||
